This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Further information

TOLERANCE
Loading...

Uemoto, Shinji


Publications

Impact Factor

Cites


ReferenceImpact FactorCitesQuartile
Takatsuki M, Uemoto S, Inomata Y, Egawa H, Kiuchi T, Fujita S, Hayashi M, Kanematsu T, Tanaka K. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation. 2001 Aug 15;72(3):449-54. PubMed PMID: 11502975.
4.546
229
1
Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, Wood KJ, Haga H, Ueda M, Uemoto S. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol. 2007 Feb;17(2):94-7. Epub 2006 Nov 10. PubMed PMID: 17306739.
1.624
145
3
Li Y, Zhao X, Cheng D, Haga H, Tsuruyama T, Wood K, Sakaguchi S, Tanaka K, Uemoto S, Koshiba T. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation. 2008 Dec 27;86(12):1837-43. doi: 10.1097/TP.0b013e31818febc4. PubMed PMID: 19104431.
4.546
96
1
Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation. 2009 Feb 27;87(4):606-14. doi: 10.1097/TP.0b013e318195a7cb. Erratum in: Transplantation. 2009 Apr 15;87(7):1104. PubMed PMID: 19307800.
4.546
89
1
Ohe H, Uchida Y, Yoshizawa A, Hirao H, Taniguchi M, Maruya E, Yurugi K, Hishida R, Maekawa T, Uemoto S, Terasaki PI. Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal. Transplantation. 2014 Nov 27;98(10):1105-11. doi: 10.1097/TP.0000000000000185. PubMed PMID: 24914568.
4.546
70
1
Zhao X, Li Y, Ohe H, Nafady-Hego H, Uemoto S, Bishop GA, Koshiba T. Intragraft Vδ1 γδ T cells with a unique T-cell receptor are closely associated with pediatric semiallogeneic liver transplant tolerance. Transplantation. 2013 Jan 15;95(1):192-202. doi: 10.1097/TP.0b013e3182782f9f. PubMed PMID: 23222896.
4.546
38
1
Nafady-Hego H, Li Y, Ohe H, Zhao X, Satoda N, Sakaguchi S, Wood K, Uemoto S, Koshiba T. The generation of donor-specific CD4+CD25++CD45RA+ naive regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation. Transplantation. 2010 Dec 27;90(12):1547-55. doi: 10.1097/TP.0b013e3181f9960d. PubMed PMID: 21085066.
4.546
36
1
Fujiki M, Esquivel CO, Martinez OM, Strober S, Uemoto S, Krams SM. Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells. Liver Transpl. 2010 Feb;16(2):147-54. doi: 10.1002/lt.21963. PubMed PMID: 20104482; PubMed Central PMCID: PMC2937179.
4.57
34
1
Egawa H, Miyagawa-Hayashino A, Haga H, Teramukai S, Yoshizawa A, Ogawa K, Ogura Y, Okamoto S, Kaido T, Uemoto S. Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal. Hepatol Res. 2012 Sep;42(9):895-903. doi: 10.1111/j.1872-034X.2012.01003.x. Epub 2012 Apr 23. PubMed PMID: 22524409.
3.165
34
3
Ohe H, Waki K, Yoshitomi M, Morimoto T, Nafady-Hego H, Satoda N, Li Y, Zhao X, Sakaguchi S, Uemoto S, Bishop GA, Koshiba T. Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match. Transpl Int. 2012 Jan;25(1):97-106. doi: 10.1111/j.1432-2277.2011.01389.x. Epub 2011 Nov 26. PubMed PMID: 22117557.
3.177
33
1
Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, Oike F, Kaihara S, Egawa H, Tanaka K. Role of HLA compatibility in pediatric living-related liver transplantation. Transplantation. 2002 Oct 27;74(8):1175-80. PubMed PMID: 12438966.
4.546
30
1
Oike F, Yokoi A, Nishimura E, Ogura Y, Fujimoto Y, Kasahara M, Kaihara S, Kiuchi T, Egawa H, Uemoto S, Tanaka K. Complete withdrawal of immunosuppression in living donor liver transplantation. Transplant Proc. 2002 Aug;34(5):1521. PubMed PMID: 12176465.
0.784
27
4
Kawasaki M, Iwasaki M, Koshiba T, Fujino M, Hara Y, Kitazawa Y, Kimura H, Uemoto S, Li XK, Tanaka K. Gene expression profile analysis of the peripheral blood mononuclear cells from tolerant living-donor liver transplant recipients. Int Surg. 2007 Sep-Oct;92(5):276-86. PubMed PMID: 18399100.
0.056
21
4
Aini W, Miyagawa-Hayashino A, Ozeki M, Adeeb S, Hirata M, Tamaki K, Uemoto S, Haga H. Accelerated telomere reduction and hepatocyte senescence in tolerated human liver allografts. Transpl Immunol. 2014 Aug;31(2):55-9. doi: 10.1016/j.trim.2014.06.008. Epub 2014 Jun 30. PubMed PMID: 24993398.
1.624
15
3
Aini W, Miyagawa-Hayashino A, Ozeki M, Tsuruyama T, Tamaki K, Uemoto S, Haga H. Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome. Transpl Immunol. 2013 Mar;28(2-3):100-5. doi: 10.1016/j.trim.2012.12.002. Epub 2012 Dec 22. PubMed PMID: 23268137.
1.624
7
3
Hai Nam N, Taura K, Koyama Y, Nishio T, Yamamoto G, Uemoto Y, Kimura Y, Xuefeng L, Nakamura D, Yoshino K, Ogawa E, Okamoto T, Yoshizawa A, Seo S, Iwaisako K, Yoh T, Hata K, Masui T, Okajima H, Haga H, Uemoto S, Hatano E. Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal. Liver Transpl. 2021 Oct 16. doi: 10.1002/lt.26336. [Epub ahead of print] PubMed PMID: 34655506.
4.57
2
Yoshioka Y, Oshima Y, Hata K, Sato S, Hamada R, Sato T, Kaido T, Munekage F, Ito T, Ikeguchi R, Uemoto S, Hatano E, Matsuda S. Factors associated with early postoperative exercise tolerance after living-donor liver transplantation. Clin Transplant. 2022 Aug 22:e14800. doi: 10.1111/ctr.14800. [Epub ahead of print] PubMed PMID: 35993374.
3.456
1
Badawy A, Kaido T, Atsushi Y, Yagi S, Hata K, Kamo N, Fukumitsu K, Okajima H, Uemoto S. Evans Syndrome After Successful Immunosuppressant-Free Living-Donor Liver Transplant. Exp Clin Transplant. 2020 Apr;18(2):258-260. doi: 10.6002/ect.2018.0005. Epub 2018 Jun 18. PubMed PMID: 29911962.
0.852
0
4
Tajima T, Hata K, Kageyama S, Kusakabe J, Yurugi K, Hishida R, Ohe H, Mori A, Okajima H, Nagao M, Uemoto S, Hatano E. The Highest Anti-B Antibody Titer of 8192 in a Patient Undergoing ABO-incompatible Living-donor Liver Transplantation: How to Achieve Donor-specific B-cell Tolerance? Transplant Direct. 2025 Aug 22;11(9):e1859. doi: 10.1097/TXD.0000000000001859. eCollection 2025 Sep. No abstract available. PubMed PMID: 40862213; PubMed Central PMCID: PMC12377316.

Data Sources

PubMed
NCBI
SemanticScholar
Web of Science
Human Phenotype ontology
KEGG
IMIB-Arrixaca

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain

E-mail

Phones

+34 968885229
+34 968885239
+34 968885249

Advanced Charts